1 | (R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4- | 1件: Pyrazole Pyrazole | - | - | - | 1件: 75 75 |
2 | (R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-4,4A,5,6,7,8-HEXAHYDRO-1H-PYRAZOLO[3,4-G]ISOQUINOLIN-4A-YL)(4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE | 1件: Pyrazole Pyrazole | - | - | - | 1件: 75 75 |
3 | (R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)4,4A,5,6,7,8-HEXAHYDRO-1H-PYRAZOLO[3,4-G]ISOQUINOLIN-4A-YL)(4(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE | 1件: Pyrazole Pyrazole | - | - | - | 1件: 75 75 |
4 | (R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4YL)SULFONYL)4,4A,5,6,7,8HEXAHYDRO-1H-PYRAZOLO[3,4-G]ISOQUINOLIN4AYL)(4(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE | 1件: Pyrazole Pyrazole | - | - | - | 1件: 75 75 |
5 | 11-beta-hydroxysteroid dehydrogenase type 1 | - | - | - | - | 1件: 75 75 |
6 | 11-ß-hydroxysteroid dehydrogenase type 1 | - | - | - | - | 1件: 75 75 |
7 | 17beta-hydroxy-11beta-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one | - | - | - | - | 1件: 75 75 |
8 | 17ß-hydroxy-11ß-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one | - | - | - | - | 1件: 75 75 |
9 | 18F-DOPA | - | - | - | - | 2件: 6 6, 75 |
10 | 1H-Pyrazol | 1件: Pyrazole Pyrazole | - | - | - | 5件: 2 2, 28, 46, 75, 154 |
11 | 2S,4R-(-)-ketoconazole | 1件: Ketoconazole Ketoconazole | 1件: D00351
D00351
| 1件: CYP17A1 CYP17A1 💬 | 6件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
12 | 2S,4R-(-)-ketoconazole, levoketoconazole | 2件: Ketoconazole Ketoconazole, Levoketoconazole | 2件: D00351
D00351
,
D10950
| 3件: CYP11A1 CYP11A1, CYP11B1, CYP17A1 💬 | 7件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
13 | Abiraterone | 1件: Abiraterone Abiraterone | - | - | - | 2件: 75 75, 81 |
14 | Abiraterone Acetate | 2件: Abiraterone Abiraterone, Acetate | - | - | - | 2件: 75 75, 81 |
15 | Abiraterone acetato | 1件: Abiraterone Abiraterone | - | - | - | 1件: 75 75 |
16 | Acetate | 1件: Acetate Acetate | - | - | - | 41件: 1 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 |
17 | Acthrel | 1件: Corticorelin ovine triflutate Corticorelin ovine triflutate | 1件: D03592
D03592
| 2件: CRHR1 CRHR1, CRHR2 💬 | 4件: Cushing syndrome Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
18 | Alprazolam | 1件: Alprazolam Alprazolam | 1件: D00225
D00225
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 8 8, 75 |
19 | ATR-101 | - | - | - | - | 2件: 75 75, 81 |
20 | AZD4017 | - | - | - | - | 1件: 75 75 |
21 | AZD4017 and prednisolone | 1件: Prednisolone Prednisolone | 1件: D00472
D00472
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 75 75 |
22 | Bexarotene | 1件: Bexarotene Bexarotene | 1件: D03106
D03106
| 3件: RXRA RXRA, RXRB, RXRG 💬 | 17件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬 | 2件: 13 13, 75 |
23 | CABERGOLINA | 1件: Cabergoline Cabergoline | 1件: D00987
D00987
| 2件: DRD2 DRD2, PRL 💬 | 12件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 75 |
24 | Cabergoline | 1件: Cabergoline Cabergoline | 1件: D00987
D00987
| 2件: DRD2 DRD2, PRL 💬 | 12件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 6 6, 74, 75 |
25 | CABERGOLINE TEVA | 1件: Cabergoline Cabergoline | 1件: D00987
D00987
| 2件: DRD2 DRD2, PRL 💬 | 12件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 75 75 |
26 | Calcium | 1件: Calcium Calcium | - | - | - | 27件: 6 6, 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 156, 214, 215, 222, 224, 235, 265, 274, 298, 299 |
27 | Calcium carbonate | 2件: Calcium Calcium, Carbonate ion | - | - | - | 8件: 13 13, 19, 46, 53, 75, 96, 235, 299 |
28 | Carbonate | 1件: Carbonate ion Carbonate ion | - | - | - | 12件: 2 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 |
29 | CI-984 | - | - | - | - | 1件: 75 75 |
30 | CIALIS - 20 MG 2 COMPRESSE RIVESTITE CON FILM IN BLISTER USO ORALE | 1件: Tadalafil Tadalafil | 1件: D02008
D02008
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 75 75 |
31 | COR-003 | - | - | - | - | 1件: 75 75 |
32 | CORT125134 | 1件: Relacorilant Relacorilant | 1件: D11336
D11336
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 75 75 |
33 | Corticotropin | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 7件: 2 2, 13, 46, 75, 81, 84, 222 |
34 | Corticotropin-releasing hormone | 2件: Corticorelin Corticorelin, Corticotropin | 2件: D00146
D00146
,
D03905
| 3件: CRHR1 CRHR1, CRHR2, MC2R 💬 | 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
35 | Cushing's syndrome confirmation | - | - | - | - | 1件: 75 75 |
36 | Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D) Trp-Ly di-aspartate | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
37 | Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Ly di-aspartate | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
38 | Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe) di-aspartate | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
39 | Cyclo(diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe) | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
40 | Dabigatran | 1件: Dabigatran Dabigatran | 1件: D09707
D09707
| 1件: F2 F2 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | 5件: 51 51, 75, 85, 91, 124 |
41 | Dabigatran etexilate | 2件: Dabigatran Dabigatran, Dabigatran etexilate | 2件: D07144
D07144
,
D09707
| 1件: F2 F2 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | 2件: 51 51, 75 |
42 | DDAVP | 1件: Desmopressin Desmopressin | 1件: D00291
D00291
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 2件: 75 75, 288 |
43 | DOSTINEX | 1件: Cabergoline Cabergoline | 1件: D00987
D00987
| 2件: DRD2 DRD2, PRL 💬 | 12件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 75 75 |
44 | Eplerenone | 1件: Eplerenone Eplerenone | 1件: D01115
D01115
| 1件: NR3C2 NR3C2 💬 | 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 4件: 75 75, 113, 210, 215 |
45 | F18CETO | - | - | - | - | 1件: 75 75 |
46 | G02CB03 | - | - | - | - | 1件: 75 75 |
47 | Gefitinib | 1件: Gefitinib Gefitinib | 1件: D01977
D01977
| 1件: EGFR EGFR 💬 | 48件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis 💬 | 1件: 75 75 |
48 | Genotropin 12mg | 1件: Somatotropin Somatotropin | - | - | - | 3件: 74 74, 75, 78 |
49 | Genotropin 5.3mg | 1件: Somatotropin Somatotropin | - | - | - | 3件: 74 74, 75, 78 |
50 | Genotropin Miniqu | 1件: Somatotropin Somatotropin | - | - | - | 3件: 74 74, 75, 78 |
51 | Genotropin Miniquick 0.2mg | 1件: Somatotropin Somatotropin | - | - | - | 3件: 74 74, 75, 78 |
52 | Genotropin Miniquick 0.4mg | 1件: Somatotropin Somatotropin | - | - | - | 3件: 74 74, 75, 78 |
53 | Genotropin Miniquick 0.6mg | 1件: Somatotropin Somatotropin | - | - | - | 3件: 74 74, 75, 78 |
54 | Genotropin Miniquick 0.8mg | 1件: Somatotropin Somatotropin | - | - | - | 3件: 74 74, 75, 78 |
55 | Genotropin Miniquick 1.0mg | 1件: Somatotropin Somatotropin | - | - | - | 3件: 74 74, 75, 78 |
56 | Genotropin Miniquick 1.2mg | 1件: Somatotropin Somatotropin | - | - | - | 3件: 74 74, 75, 78 |
57 | Glucocorticoids | - | - | - | - | 8件: 40 40, 41, 43, 44, 60, 62, 75, 300 |
58 | Glucophage (metformin) | 1件: Metformin Metformin | 1件: D04966
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 2件: 46 46, 75 |
59 | HRA052015 | - | - | - | - | 1件: 75 75 |
60 | HRA052015 (mifepristone) | 1件: Mifepristone Mifepristone | 1件: D00585
D00585
| 2件: NR3C1 NR3C1, PGR 💬 | 6件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 75 75 |
61 | Hydrocortisone | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 10件: 6 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 |
62 | Hypro | - | - | - | - | 1件: 75 75 |
63 | Insulin | - | - | - | - | 6件: 6 6, 13, 46, 75, 78, 299 |
64 | Ketoconazole | 1件: Ketoconazole Ketoconazole | 1件: D00351
D00351
| 1件: CYP17A1 CYP17A1 💬 | 6件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | 3件: 8 8, 13, 75 |
65 | L0006CP03A | - | - | - | - | 1件: 75 75 |
66 | L01XX14 | - | - | - | - | 1件: 75 75 |
67 | Lapatinib | 1件: Lapatinib Lapatinib | 1件: D08108
D08108
| 2件: EGFR EGFR, ERBB2 💬 | 50件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction 💬 | 3件: 34 34, 74, 75 |
68 | LCI699 | - | - | - | - | 1件: 75 75 |
69 | LCI699, 1 mg | - | - | - | - | 1件: 75 75 |
70 | LCI699, 10 mg | - | - | - | - | 1件: 75 75 |
71 | LCI699, 20 mg | - | - | - | - | 1件: 75 75 |
72 | LCI699, 5 mg | - | - | - | - | 1件: 75 75 |
73 | Levoketoconazole | 1件: Levoketoconazole Levoketoconazole | 1件: D10950
D10950
| 3件: CYP11A1 CYP11A1, CYP11B1, CYP17A1 💬 | 7件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
74 | Levoketozonazole | - | - | - | - | 1件: 75 75 |
75 | Liqourice | - | - | - | - | 1件: 75 75 |
76 | Liraglutide | 1件: Liraglutide Liraglutide | 1件: D06404
D06404
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 3件: 6 6, 75, 193 |
77 | Matyrapone | - | - | - | - | 1件: 75 75 |
78 | Metformin | 1件: Metformin Metformin | 1件: D04966
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 25件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301 |
79 | Metopirone | 1件: Metyrapone Metyrapone | 1件: D00410
D00410
| 1件: CYP11B1 CYP11B1 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
80 | Metopirone 250 mg capsules | 1件: Metyrapone Metyrapone | 1件: D00410
D00410
| 1件: CYP11B1 CYP11B1 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
81 | Metopirone 250 mg capsules/ Cormeto | 1件: Metyrapone Metyrapone | 1件: D00410
D00410
| 1件: CYP11B1 CYP11B1 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
82 | Metopirone 250 mg capsules/Cormeto | 1件: Metyrapone Metyrapone | 1件: D00410
D00410
| 1件: CYP11B1 CYP11B1 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
83 | METYRAPONE | 1件: Metyrapone Metyrapone | 1件: D00410
D00410
| 1件: CYP11B1 CYP11B1 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
84 | Mifedren | - | - | - | - | 1件: 75 75 |
85 | MIFEPRISTONE | 1件: Mifepristone Mifepristone | 1件: D00585
D00585
| 2件: NR3C1 NR3C1, PGR 💬 | 6件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 75 75 |
86 | Nevanimibe | 1件: Nevanimibe Nevanimibe | 1件: D11300
D11300
| - | - | 2件: 75 75, 81 |
87 | Nevanimibe hydrochloride | 1件: Nevanimibe Nevanimibe | 1件: D11300
D11300
| - | - | 2件: 75 75, 81 |
88 | NIZORAL | 1件: Ketoconazole Ketoconazole | 1件: D00351
D00351
| 1件: CYP17A1 CYP17A1 💬 | 6件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
89 | NON COMMERCIAL | - | - | - | - | 1件: 75 75 |
90 | OCRH | - | - | - | - | 2件: 75 75, 232 |
91 | Octreotide | 1件: Octreotide Octreotide | 1件: D00442
D00442
| 1件: SSTR2 SSTR2 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 7件: 67 67, 75, 84, 85, 89, 193, 227 |
92 | OROCAL | - | - | - | - | 1件: 75 75 |
93 | OSILODROSTAT | 1件: Osilodrostat Osilodrostat | 1件: D11061
D11061
| 1件: CYP11B2 CYP11B2 💬 | 3件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
94 | Osilodrostat 10mg | 1件: Osilodrostat Osilodrostat | 1件: D11061
D11061
| 1件: CYP11B2 CYP11B2 💬 | 3件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
95 | Osilodrostat 1mg | 1件: Osilodrostat Osilodrostat | 1件: D11061
D11061
| 1件: CYP11B2 CYP11B2 💬 | 3件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
96 | Osilodrostat 20mg | 1件: Osilodrostat Osilodrostat | 1件: D11061
D11061
| 1件: CYP11B2 CYP11B2 💬 | 3件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
97 | Osilodrostat 5mg | 1件: Osilodrostat Osilodrostat | 1件: D11061
D11061
| 1件: CYP11B2 CYP11B2 💬 | 3件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
98 | Ossein hydroxyapatite | - | - | - | - | 1件: 75 75 |
99 | OSTEOPOR | - | - | - | - | 1件: 75 75 |
100 | Ovine Corticotropin-Releasing Hormone (oCRH) | 2件: Corticorelin Corticorelin, Corticotropin | 2件: D00146
D00146
,
D03905
| 3件: CRHR1 CRHR1, CRHR2, MC2R 💬 | 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
101 | Pasireotida | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
102 | Pasireotida 300 | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
103 | Pasireotida 600 | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
104 | Pasireotida 900 | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
105 | Pasireotide | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 3件: 67 67, 74, 75 |
106 | Pasireotide 0.3mg | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
107 | Pasireotide 0.6 MG/ML | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
108 | Pasireotide 0.6mg | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
109 | Pasireotide 0.9 mg | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
110 | Pasireotide 20mg | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
111 | Pasireotide 40mg | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
112 | Pasireotide 60mg | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
113 | PASIREOTIDE DIASPARTATE | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
114 | Pasireotide LAR | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 2件: 67 67, 75 |
115 | PASIREOTIDE PAMOATE | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
116 | Pasireotide s.c. | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
117 | Pasireotide sub-cutaneous | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
118 | Pasireotide with or without cabergoline | 2件: Cabergoline Cabergoline, Pasireotide | 2件: D00987
D00987
,
D10147
| 6件: DRD2 DRD2, PRL, SSTR1, SSTR2, SSTR3, SSTR5 💬 | 14件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 75 75 |
119 | Pasireotode | - | - | - | - | 1件: 75 75 |
120 | Pentetreotide | 1件: Pentetreotide Pentetreotide | 1件: D01859
D01859
| - | - | 1件: 75 75 |
121 | Phe | - | - | - | - | 1件: 75 75 |
122 | PREDNISOLONE | 1件: Prednisolone Prednisolone | 1件: D00472
D00472
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 42件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
123 | R-roscovitine | 1件: Seliciclib Seliciclib | - | - | - | 1件: 75 75 |
124 | Relacorilant | 1件: Relacorilant Relacorilant | 1件: D11336
D11336
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 75 75 |
125 | Rosiglitazone | 1件: Rosiglitazone Rosiglitazone | 1件: D08491
D08491
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 5件: 46 46, 75, 97, 222, 265 |
126 | Rosiglitazone maleate | 1件: Rosiglitazone Rosiglitazone | 1件: D08491
D08491
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 3件: 46 46, 75, 265 |
127 | RVG 08938 | - | - | - | - | 1件: 75 75 |
128 | RVG 15375 | - | - | - | - | 1件: 75 75 |
129 | RVG 18236 | - | - | - | - | 2件: 75 75, 227 |
130 | Seliciclib | 1件: Seliciclib Seliciclib | - | - | - | 2件: 75 75, 299 |
131 | SIGNIFOR | 1件: Pasireotide Pasireotide | 1件: D10147
D10147
| 4件: SSTR1 SSTR1, SSTR2, SSTR3, SSTR5 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 75 75 |
132 | Silycus | - | - | - | - | 1件: 75 75 |
133 | Sitagliptin | 1件: Sitagliptin Sitagliptin | 1件: D08516
D08516
| 1件: DPP4 DPP4 💬 | 1件: Protein digestion and absorption Protein digestion and absorption 💬 | 4件: 6 6, 75, 233, 299 |
134 | SOM230 | - | - | - | - | 2件: 74 74, 75 |
135 | SOM230 300µg | - | - | - | - | 1件: 75 75 |
136 | SOM230 600µg | - | - | - | - | 1件: 75 75 |
137 | SOM230 900µg | - | - | - | - | 1件: 75 75 |
138 | SOM230 LAR | - | - | - | - | 1件: 75 75 |
139 | SOM230 LAR 10 mg | - | - | - | - | 1件: 75 75 |
140 | SOM230 LAR 30 mg | - | - | - | - | 1件: 75 75 |
141 | SOM230 LAR, 20 mg | - | - | - | - | 1件: 75 75 |
142 | SOM230 s.c. | - | - | - | - | 1件: 75 75 |
143 | SOM230, 300micrograms | - | - | - | - | 1件: 75 75 |
144 | SOM230, 600 micrograms | - | - | - | - | 1件: 75 75 |
145 | SOM230, 900 micrograms | - | - | - | - | 1件: 75 75 |
146 | SOM230B | - | - | - | - | 1件: 75 75 |
147 | Somatropin | 1件: Somatotropin Somatotropin | - | - | - | 19件: 2 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 |
148 | SPI-62 | - | - | - | - | 1件: 75 75 |
149 | SPI-62 dose 2 | - | - | - | - | 1件: 75 75 |
150 | SPI-62 dose 3 | - | - | - | - | 1件: 75 75 |
151 | SPI-62 dose 4 | - | - | - | - | 1件: 75 75 |
152 | SPI-62 dose1 | - | - | - | - | 1件: 75 75 |
153 | Tadalafil | 1件: Tadalafil Tadalafil | 1件: D02008
D02008
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 7件: 6 6, 51, 75, 84, 86, 113, 210 |
154 | Tretinoin | 1件: Tretinoin Tretinoin | 1件: D00094
D00094
| 3件: PML PML, RARA, RARB 💬 | 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 3件: 2 2, 62, 75 |
155 | TRETINOINA | 1件: Tretinoin Tretinoin | 1件: D00094
D00094
| 3件: PML PML, RARA, RARB 💬 | 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 75 75 |
156 | Trp | - | - | - | - | 1件: 75 75 |
157 | Tyr | - | - | - | - | 2件: 75 75, 298 |
158 | Valsartan | 1件: Valsartan Valsartan | 1件: D00400
D00400
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 7件: 57 57, 58, 66, 75, 218, 222, 224 |
159 | VESANOID | 1件: Tretinoin Tretinoin | 1件: D00094
D00094
| 3件: PML PML, RARA, RARB 💬 | 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 75 75 |
160 | Vorinostat | 1件: Vorinostat Vorinostat | 1件: D06320
D06320
| 11件: HDAC1 HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬 | 2件: 75 75, 96 |
161 | ZYTIGA | 1件: Abiraterone Abiraterone | - | - | - | 1件: 75 75 |
162 | ZYTIGA - 250 MG - COMPRESSA - USO ORALE - FLACONE 120 COMPRESSE | 1件: Abiraterone Abiraterone | - | - | - | 1件: 75 75 |